By the end of December 2022, health care services transaction volume had declined significantly, as buyers and sellers could not coalesce around the effects of increased labor costs and scarce availability on the future businesses of the seller, according to Weaver’s Health Care in Review.
“In 2023 and beyond, we expect health systems and private equity-backed platforms to continue consolidating to achieve more scale, and to re-invest in digital technology and alternate sites of care,” Weaver analysts note. “However, due to increased cost and reduced availability of capital, we expect that buyers will be more selective and transactions will reflect a flight to quality.”
The report covers healthcare staffing, rising expenses, maximizing profits, valuations, innovation and demographic trends, telehealth, ASC growth and more. Read the report.
